| TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data A Colaprico, TC Silva, C Olsen, L Garofano, C Cava, D Garolini, ... Nucleic acids research 44 (8), e71-e71, 2016 | 2887 | 2016 |
| MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer G Bertoli, C Cava, I Castiglioni Theranostics 5 (10), 1122, 2015 | 837 | 2015 |
| MicroRNAs as biomarkers for diagnosis, prognosis and theranostics in prostate cancer G Bertoli, C Cava, I Castiglioni International journal of molecular sciences 17 (3), 421, 2016 | 162 | 2016 |
| In silico discovery of candidate drugs against Covid-19 C Cava, G Bertoli, I Castiglioni Viruses 12 (4), 404, 2020 | 144 | 2020 |
| Interpreting pathways to discover cancer driver genes with Moonlight A Colaprico, C Olsen, MH Bailey, GJ Odom, T Terkelsen, TC Silva, ... Nature communications 11 (1), 69, 2020 | 82 | 2020 |
| Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer L Cantini, G Bertoli, C Cava, T Dubois, A Zinovyev, M Caselle, ... Nucleic acids research 47 (5), 2205-2215, 2019 | 77 | 2019 |
| Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition C Cava, G Bertoli, M Ripamonti, G Mauri, I Zoppis, PAD Rosa, MC Gilardi, ... PloS one 9 (5), e97681, 2014 | 70 | 2014 |
| Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential C Cava, G Bertoli, I Castiglioni BMC systems biology 9, 1-36, 2015 | 63 | 2015 |
| Comparison of data-merging methods with SVM attribute selection and classification in breast cancer gene expression VB Stefania Tommasi, Paolo Pannarale, Mirko Abbrescia, Claudia Cava Lecture Notes in Computer Science (including subseries Lecture Notes in …, 2011 | 52* | 2011 |
| SpidermiR: an R/bioconductor package for integrative analysis with miRNA data C Cava, A Colaprico, G Bertoli, A Graudenzi, TC Silva, C Olsen, ... International journal of molecular sciences 18 (2), 274, 2017 | 51 | 2017 |
| Potential role of miRNAs as theranostic biomarkers of epilepsy C Cava, I Manna, A Gambardella, G Bertoli, I Castiglioni Molecular Therapy-Nucleic Acids 13, 275-290, 2018 | 43 | 2018 |
| Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis C Cava, G Bertoli, A Colaprico, C Olsen, G Bontempi, I Castiglioni BMC genomics 19 (1), 1-16, 2018 | 39 | 2018 |
| Circulating microRNAs as potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy: a pilot study S De Benedittis, F Fortunato, C Cava, F Gallivanone, E Iaccino, ... International Journal of Molecular Sciences 22 (2), 702, 2021 | 38 | 2021 |
| Integrative Analysis with Monte Carlo Cross‐Validation Reveals miRNAs Regulating Pathways Cross‐Talk in Aggressive Breast Cancer A Colaprico, C Cava, G Bertoli, G Bontempi, I Castiglioni BioMed research international 2015 (1), 831314, 2015 | 38 | 2015 |
| MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration G Bertoli, C Cava, C Diceglie, C Martelli, G Rizzo, F Piccotti, L Ottobrini, ... Breast cancer research and treatment 161, 605-616, 2017 | 37 | 2017 |
| Integration of molecular docking and in vitro studies: a powerful approach for drug discovery in breast cancer C Cava, I Castiglioni Applied Sciences 10 (19), 6981, 2020 | 33 | 2020 |
| Radiation-induced gene expression changes in high and low grade breast cancer cell types V Bravatà, C Cava, L Minafra, FP Cammarata, G Russo, MC Gilardi, ... International journal of molecular sciences 19 (4), 1084, 2018 | 32 | 2018 |
| The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer G Bertoli, C Cava, I Castiglioni Scandinavian Journal of Clinical and Laboratory Investigation 76 (sup245 …, 2016 | 32 | 2016 |
| Portrait of Tissue‐Specific Coexpression Networks of Noncoding RNAs (miRNA and lncRNA) and mRNAs in Normal Tissues C Cava, G Bertoli, I Castiglioni Computational and Mathematical Methods in Medicine 2019 (1), 9029351, 2019 | 30 | 2019 |
| Theranostic application of miR-429 in HER2+ breast cancer C Cava, C Novello, C Martelli, AL Dico, L Ottobrini, F Piccotti, M Truffi, ... Theranostics 10 (1), 50, 2020 | 29 | 2020 |
